Works matching Bubonic plague vaccine
Results: 7
Design and Testing for a Nontagged F1-V Fusion Protein as Vaccine Antigen against Bubonic and Pneumonic Plague.
- Published in:
- Biotechnology Progress, 2005, v. 21, n. 5, p. 1490, doi. 10.1021/bp050098r
- By:
- Publication type:
- Article
Plague vaccine research and development.
- Published in:
- Journal of Applied Microbiology, 2001, v. 91, n. 4, p. 606, doi. 10.1046/j.1365-2672.2001.01497.x
- By:
- Publication type:
- Article
Biological War and Chemical Warfare-Status of AIDS.
- Published in:
- Indian Journal of Public Health Research & Development, 2018, v. 9, n. 4, p. 165, doi. 10.5958/0976-5506.2018.00276.0
- By:
- Publication type:
- Article
Editorial: Insights in infectious agents and disease: 2022.
- Published in:
- Frontiers in Microbiology, 2024, p. 01, doi. 10.3389/fmicb.2024.1443636
- By:
- Publication type:
- Article
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-020-00275-3
- By:
- Publication type:
- Article
Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.726416
- By:
- Publication type:
- Article
The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0007023
- By:
- Publication type:
- Article